- Experimental therapy with 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): Origin of resistance2007 | 2. lékařská fakulta
- Expression of MRP4 and MRP5 genes is related to the PMEDAP resistance in SD lymphomaPublikace bez příslušnosti k fakultě
- Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG2011 | Přírodovědecká fakulta
